ADHD Medication: Stimulants vs Non-Stimulants

THE SHORT ANSWER

Stimulants are the most effective ADHD medications and work the first day; about seven in ten children respond to the first one tried. Non-stimulants are slower and somewhat less effective but work around the clock, are not controlled substances, and fit better when anxiety, tics, sleep problems or diversion risk are present. I choose with each family, not for them.

Once I have made a diagnosis of ADHD and a family has decided to consider medication, we arrive at a decision I make with every family, never for them: a stimulant, a non-stimulant, or both. The question comes with a lot of inherited opinion. Some parents arrive certain they want nothing to do with stimulants. Others have a cousin who did well on one and want the same. Here is how I lay out the choice.

Two kinds of stimulant

Stimulants are the most effective medications for ADHD and have been studied in children for more than 60 years. There are two chemical families: methylphenidate (Ritalin, Concerta, Focalin and others) and amphetamine (Adderall, Vyvanse, Evekeo and others). Within each family there are short-acting forms that last three to four hours and long-acting forms that last eight to twelve or more. Most methylphenidate and amphetamine products are FDA-approved from age 6, and a few amphetamine products are approved from age 3, though I rarely use them that young.

The Multimodal Treatment Study of ADHD, the largest trial of its kind, found that carefully managed stimulant medication reduced core ADHD symptoms more than behavioral treatment alone over 14 months, and that the combination was best for many children, particularly those with anxiety or difficult family circumstances. The American Academy of Pediatrics guideline reflects this: for children 6 and older, FDA-approved medication plus behavioral and school supports is the recommended approach.

In practice, about seven in ten children respond well to the first stimulant tried, and most of the rest respond to the other family. A child who does poorly on methylphenidate may do very well on an amphetamine, or the reverse. I tell families at the start that the first prescription is a trial, not a verdict.

What stimulants do well and where they fall short

They work fast. A correctly dosed stimulant works the first day it is taken, and the teacher often notices before the parent does. They are also easy to stop; they are out of the system by the next morning, so a weekend or summer off is possible if a family wants it.

The side effects are predictable. Reduced appetite, especially at lunch, is the most common. Trouble falling asleep if the dose lasts too late into the evening. Stomachache and headache early on. Some children become flat or irritable as the dose wears off in the late afternoon. Heart rate and blood pressure rise slightly, which I check at every visit. Height gain can slow modestly over the first few years, which is why I track growth. Tics may become more noticeable in a child who already has them, though the evidence that stimulants cause tics is weak.

Stimulants are Schedule II controlled substances. That means a new prescription every month, no automatic refills, and a pharmacy that may not have the product in stock. The nationwide shortages that began in 2022 have been a genuine burden on families, and I plan for them: I know which products are available locally and I write prescriptions that give the pharmacist room to substitute.

The non-stimulants

Four non-stimulant medications are FDA-approved for ADHD in children. Atomoxetine (Strattera) and viloxazine (Qelbree) work on norepinephrine. Guanfacine extended-release (Intuniv) and clonidine extended-release (Kapvay) are alpha-2 agonists originally developed for blood pressure. All four are approved from age 6.

They are less effective than stimulants for core symptoms on average, and they are slow. Atomoxetine and viloxazine take several weeks to reach full effect. Guanfacine and clonidine take a week or two. They work around the clock rather than wearing off, which is an advantage for mornings and evenings and a disadvantage for a family that wanted medication only on school days.

Their side effects differ. Atomoxetine can cause stomach upset and sleepiness, and carries an FDA boxed warning about suicidal thinking in children and teens, which is rare but which I discuss. Viloxazine carries the same warning. Guanfacine and clonidine cause sleepiness and can lower blood pressure, and they must be tapered rather than stopped suddenly. None are controlled substances, so refills are simple and shortages are rare.

When I lean toward a non-stimulant

I reach for a non-stimulant first, or add one, in several situations.

When a child has a significant anxiety disorder alongside ADHD. Stimulants can sharpen anxiety in some children, and atomoxetine treats both to a degree.
When tics are prominent. Guanfacine has evidence for tics and ADHD together.
When the main problem is impulsivity, aggression or sleep rather than inattention. The alpha-2 agonists help with those, and I often add guanfacine or clonidine to a stimulant for this reason.
When a family has a history of substance use disorder in the home and the risk of diversion is real. Non-stimulants have no street value.
When a child has had a cardiac condition that makes a stimulant inappropriate. I follow the American Heart Association and AAP guidance: a careful history and exam for every child, and an ECG or cardiology referral when the history raises a flag.
When two stimulant trials have failed or produced side effects the family cannot live with.

How the decision actually happens

I tell the family what I have observed and which option I would choose if it were my child, and why. Then I ask what matters most to them. For some it is school performance above all. For others it is a child who can eat dinner and fall asleep. For others it is avoiding a controlled substance. There is no wrong priority, and the right medication for one family is the wrong one for another with the same child on paper.

We pick a starting point together. I start at a low dose and increase every one to two weeks, with a teacher rating scale and a parent rating scale at each step, until the symptoms are controlled or the side effects say stop. I see the child within a month of starting and I measure height, weight, pulse and blood pressure. If the first choice is not right, we try the other stimulant family or move to a non-stimulant. Most families find the right fit within two or three months.

I also tell families what medication does not do. It does not teach organization, it does not repair a year of lost confidence, and it does not replace the school supports a child with ADHD is entitled to. Those pieces are part of the plan from the first visit, whether the pill is a stimulant or not.

Frequently asked questions

Are stimulants safe for a child's heart?

For children with no cardiac history and a normal exam, yes; stimulants raise heart rate and blood pressure slightly, which I check at each visit. Following American Heart Association and AAP guidance, I take a careful history and refer for an ECG or cardiology evaluation when something in the history raises a flag.

Will my child have to take ADHD medication every day?

Not necessarily. Stimulants are out of the system by the next morning, so weekends or summers off are possible if a family wants that. Non-stimulants work around the clock and must be taken daily; guanfacine and clonidine must be tapered rather than stopped suddenly.

What happens if the pharmacy does not have my child's stimulant in stock?

Shortages have been common since 2022. I know which products are available locally, write prescriptions that allow substitution where possible, and will switch to an equivalent product in the same family when needed. Call the office rather than skipping doses for weeks.

More from Dr. Williams

Educational content and not a substitute for evaluation. If you are in crisis, call or text 988.

Stimulants, non-stimulants and the decision I make with every family